World News and Views :: Top of the News
Merck KGaA Acquires Chinese Biotech Firm
1:06 AM MST | January 5, 2011 | Deepti Ramesh
Merck KGaA says it has acquired Beijing Skywing Technology (Beijing), a leading supplier of cell-culture media products, related technical services and bioreactors for the biopharmaceutical industry in China, for a purchase price of Rmb120 million ($18 million). The company employs about 80 people. The acquisition allows Merck to immediately establish a direct presence in this market segment in China with access to a cell-culture media portfolio, close relationships to local customers, and a facility, says Burghard Freiberg, head of Pharm Chemicals Solutions of...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee